DB17302InvestigationalGene Therapies
SNS01-T is a gene therapy nanoparticle. It is composed of three components: a B cell-specific plasmid expressing eIF5AK50R; an siRNA that targets the native eIF5A that promotes growth/anti-apoptosis of cancer...
- Code names
- SNS01-T
What you can answer from here — as of April 23, 2025
Which companies are running trials of SNS01-T, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account